Skip to main content

Advertisement

SpringerLink
Log in

Statin treatment for rheumatoid arthritis: a promising novel indication

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The results of several cross-sectional trials suggest that patients with rheumatoid arthritis (RA) have increased vascular risk and cardiovascular mortality. It was demonstrated that inflammation plays a pivotal role in the pathogenesis of both RA and atherosclerosis. This association may explain the high incidence of cardiovascular disease in RA patients. A number of recent studies show that routine statin use in patients with RA offers considerable advantages. Statin treatment has been supported to exert a beneficial effect on disease activity, swollen joint count, endothelial dysfunction, and arterial stiffness in RA patients. These improvements are coupled with a mild to moderate improvement in plasma markers of inflammation, such as C-reactive protein and erythrocyte sedimentation rate. Statins have a satisfactory safety profile with relatively few adverse effects. In the absence of side effects and contraindications, it may be reasonable to consider statin use in selected cases, particularly in patients with a long history of active RA who are at increased cardiovascular risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Walker JG, Littlejohn GO (2006) Measuring quality of life in rheumatic conditions. Clin Rheumatol 26:671–673

    Article  PubMed  Google Scholar 

  2. Palkonyai E, Kolarz G, Kopp M et al (2007) Depressive symptoms in early rheumatoid arthritis: a comparative longitudinal study. Clin Rheumatol 26:753–758

    Article  PubMed  Google Scholar 

  3. Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872–878

    Article  PubMed  Google Scholar 

  4. Birtane M, Uzunca K, Tastekin N, Tuna H (2007) The evaluation of quality of life in fibromyalgia syndrome: a comparison with rheumatoid arthritis using SF-36 Health Survey. Clin Rheumatol 26:679–684

    Article  PubMed  Google Scholar 

  5. Taal E, Bobietinska E, Lloyd J (2006) Successfully living with chronic arthritis. The role of the allied health professionals. Clin Rheumatol 25:189–197

    Article  PubMed  Google Scholar 

  6. Brooks PM (2006) The burden of musculoskeletal disease—a global perspective. Clin Rheumatol 25:778–781

    Article  PubMed  Google Scholar 

  7. Frostegard J (2005) Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 25:1776–1785

    Article  PubMed  CAS  Google Scholar 

  8. Sherer Y, Shoenfeld Y (2006) Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2:99–106

    Article  PubMed  CAS  Google Scholar 

  9. Chung CP, Avalos I, Raggi P, Stein CM (2007) Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clin Rheumatol 26:1228–1233

    Article  PubMed  Google Scholar 

  10. Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis. Arthritis Rheum 46:862–873

    Article  PubMed  Google Scholar 

  11. Van Doornum S, McColl G, Jenkins A et al (2003) Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 48:72–80

    Article  PubMed  Google Scholar 

  12. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35:8–17

    Article  PubMed  Google Scholar 

  13. Giles JT, Post W, Blumenthal RS et al (2006) Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2:320–329

    Article  PubMed  CAS  Google Scholar 

  14. Warrington KJ, Kent PD, Frye RL et al (2005) Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 7:R984–R991

    Article  PubMed  CAS  Google Scholar 

  15. Watson DJ, Rhodes T, Guess HA (2003) All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 30:1196–1202

    PubMed  Google Scholar 

  16. Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ES (2007) Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol 25:102–111

    PubMed  CAS  Google Scholar 

  17. Costenbader KH, Coblyn JS (2005) Statin therapy in rheumatoid arthritis. South Med J 98:534–540

    Article  PubMed  Google Scholar 

  18. Arnaud C, Mach F (2006) Potential antiinflammatory and immunomodulatory effects of statins in rheumatologic therapy. Arthritis Rheum 54:390–392

    Article  PubMed  CAS  Google Scholar 

  19. Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  20. Binder CJ, Chang MK, Shaw PX et al (2002) Innate and acquired immunity in atherogenesis. Nat Med 8:1218–1226

    Article  PubMed  CAS  Google Scholar 

  21. Hansson GK, Holm J, Jonasson L (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135:169–175

    PubMed  CAS  Google Scholar 

  22. Frostegard J, Ulfgren AK, Nyberg P et al (1999) Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145:33–43

    Article  PubMed  CAS  Google Scholar 

  23. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361–403

    Article  PubMed  CAS  Google Scholar 

  24. Xu Q, Dietrich H, Steiner HJ et al (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12:789–799

    PubMed  CAS  Google Scholar 

  25. George J, Harats D, Gilburd B et al (2000) Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102:1822–1827

    PubMed  CAS  Google Scholar 

  26. George J, Afek A, Gilburd B et al (1998) Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 98:1108–1115

    PubMed  CAS  Google Scholar 

  27. Mach F, Schonbeck U, Sukhova GK et al (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 394:200–203

    Article  PubMed  CAS  Google Scholar 

  28. Toubi E, Shoenfeld Y (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37:457–464

    Article  PubMed  CAS  Google Scholar 

  29. Nicoletti A, Kaveri S, Caligiuri G et al (1998) Immunoglobulin treatment reduces atherosclerosis in Apo E knockout mice. J Clin Invest 102:910–918

    Article  PubMed  CAS  Google Scholar 

  30. Robertson AK, Rudling M, Zhou X et al (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 112:1342–1350

    Article  PubMed  CAS  Google Scholar 

  31. Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307

    Article  PubMed  Google Scholar 

  32. Arthritis Research Campaign. Arthritis: the big picture. http://www.arc.org.uk/arthinfo/bigpic.asp#6. Accessed 4 November 2007

  33. Davenport G; Primary Care Rheumatology Society Steering Committee (2004) Rheumatology and musculoskeletal medicine. Br J Gen Pract 54:457–464

    PubMed  Google Scholar 

  34. Wolfe F, Mitchell DM, Sibley JT et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494

    Article  PubMed  CAS  Google Scholar 

  35. Nicola PJ, Maradit-Kremers H, Roger VL et al (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412–420

    Article  PubMed  Google Scholar 

  36. Snow MH, Mikuls TR (2005) Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 17:234–241

    Article  PubMed  Google Scholar 

  37. Maradit-Kremers H, Crowson CS, Nicola PJ et al (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411

    Article  PubMed  Google Scholar 

  38. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24:445–451

    PubMed  CAS  Google Scholar 

  39. del Rincon ID, Williams K, Stern MP et al (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745

    Article  PubMed  Google Scholar 

  40. Jacobsson LT, Turesson C, Hanson RL et al (2001) Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 44:1170–1176

    Article  PubMed  CAS  Google Scholar 

  41. Chung CP, Oeser A, Raggi P et al (2005) Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52:3045–3053

    Article  PubMed  Google Scholar 

  42. Park YB, Ahn CW, Choi HK et al (2003) Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 46:1714–1719

    Article  Google Scholar 

  43. Kumeda Y, Inaba M, Goto H et al (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46:1489–1497

    Article  PubMed  Google Scholar 

  44. Daza L, Aguirre M, Jimenez M et al (2007) Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol 26:533–537

    Article  PubMed  Google Scholar 

  45. Nagata-Sakurai M, Inaba M, Goto H et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48:3061–3067

    Article  PubMed  Google Scholar 

  46. Roman MJ, Moeller E, Davis A et al (2006) Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 144:249–256

    PubMed  Google Scholar 

  47. Dessein PH, Joffe BI (2006) When is a patient with rheumatoid arthritis at risk for cardiovascular disease? J Rheumatol 33:201–203

    PubMed  Google Scholar 

  48. Cederholm A, Svenungsson E, Jensen-Urstad K et al (2005) Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 25:198–203

    PubMed  CAS  Google Scholar 

  49. Swanberg M, Lidman O, Padyukov L et al (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37:486–494

    Article  PubMed  CAS  Google Scholar 

  50. Abeles AM, Pillinger MH (2006) Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy. Arthritis Rheum 54:393–407

    Article  PubMed  CAS  Google Scholar 

  51. Tristano AG, Fuller K (2006) Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved. Int Immunopharmacol 6:1833–1846

    Article  PubMed  CAS  Google Scholar 

  52. Agrawal S, Misra R, Aggarwal A (2007) Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 26:201–204

    Article  PubMed  Google Scholar 

  53. Turesson C (2004) Endothelial expression of MHC class II molecules in autoimmune disease. Curr Pharm Des 10:129–143

    Article  PubMed  CAS  Google Scholar 

  54. Palinski W, Napoli C (2002) Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol 22:1745–1750

    Article  PubMed  CAS  Google Scholar 

  55. Choi M, Rolle S, Rane M et al (2003) Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int 63:96–106

    Article  PubMed  CAS  Google Scholar 

  56. Sadeghi MM, Tiglio A, Sadigh K et al (2001) Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation 71:1262–1268

    Article  PubMed  CAS  Google Scholar 

  57. Kwak B, Mulhaupt F, Veillard N et al (2001) The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly 131:41–46

    PubMed  CAS  Google Scholar 

  58. Dolhain RJ, van der Heiden AN, ter Haar NT et al (1996) Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 39:1961–1969

    Article  PubMed  CAS  Google Scholar 

  59. Nagashima T, Okazaki H, Yudoh K et al (2006) Apoptosis of rheumatoid synovial cells by statins through the blocking of geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 54:579–586

    Article  PubMed  CAS  Google Scholar 

  60. McCarey DW, McInnes IB, Madhok R et al (2004) Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363:2015–2021

    Article  PubMed  CAS  Google Scholar 

  61. Hermann F, Forster A, Chenevard R et al (2005) Simvastatin improves endothelial function in patients with rheumatoid arthritis. J Am Coll Cardiol 45:461–464

    Article  PubMed  CAS  Google Scholar 

  62. Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979

    Article  PubMed  CAS  Google Scholar 

  63. Ridker PM, Buring JE, Shih J et al (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733

    PubMed  CAS  Google Scholar 

  64. Koenig W, Sund M, Frohlich M et al (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237–242

    PubMed  CAS  Google Scholar 

  65. Ridker PM, Rifai N, Rose L et al (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–1565

    Article  PubMed  CAS  Google Scholar 

  66. Pham T, Gossec L, Constantin A et al (2006) Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Jt Bone Spine 73:379–387

    Article  CAS  Google Scholar 

  67. McInnes IB, McCarey DW, Sattar N (2004) Do statins offer therapeutic potential in inflammatory arthritis. Ann Rheum Dis 63:1535–1537

    Article  PubMed  CAS  Google Scholar 

  68. Sattar N, McInnes IB (2005) Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol 17:286–292

    Article  PubMed  Google Scholar 

  69. Furberg CD, Pitt B (2001) Withdrawal of cerivastatin from the world market. Curr Control Trials Cardiovasc Med 2:205–207

    Article  PubMed  Google Scholar 

  70. Klareskog L, Hamsten A (2004) Statins in rheumatoid arthritis—two birds with one stone. Lancet 363:2011–2012

    Article  PubMed  Google Scholar 

  71. Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effects of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326:1423–1427

    Article  PubMed  CAS  Google Scholar 

  72. Rosenson RS (2004) Current overview of statin-induced myopathy. Am J Med 116:408–416

    Article  PubMed  CAS  Google Scholar 

  73. Kanda H, Hamasaki K, Kubo K et al (2002) Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis. J Rheumatol 29:2024–2026

    PubMed  Google Scholar 

  74. Abud-Mendoza C, de la Fuente H, Cuevas-Orta E et al (2003) Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Lupus 12:607–611

    Article  PubMed  CAS  Google Scholar 

  75. Van Doornum S, McColl G, Wicks IP (2004) Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 63:1571–1575

    Article  PubMed  CAS  Google Scholar 

  76. Maki-Petaja KM, Booth AD, Hall FC et al (2007) Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 50:852–858

    Article  PubMed  CAS  Google Scholar 

  77. Okamoto H, Koizumi K, Kamitsuji S et al (2007) Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort. J Rheumatol 34:964–968

    PubMed  CAS  Google Scholar 

  78. Tikiz C, Utuk O, Pirildar T et al (2005) Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. J Rheumatol 32:2095–2101

    PubMed  CAS  Google Scholar 

  79. Charles-Schoeman C, Khanna D, Furst DE et al (2007) Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol 34:1459–1464

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry (Vascular Disease Prevention Clinic), Royal Free Hospital, Pond Street, London, NW3 2QG, UK

    Kosmas I. Paraskevas

  2. Academic Department of Surgery, Royal Free Hospital, London, UK

    Kosmas I. Paraskevas

Authors
  1. Kosmas I. Paraskevas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kosmas I. Paraskevas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paraskevas, K.I. Statin treatment for rheumatoid arthritis: a promising novel indication. Clin Rheumatol 27, 281–287 (2008). https://doi.org/10.1007/s10067-007-0806-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0806-8

Keywords

Search

Navigation